ArticleCancer cell international2024

Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy.

Ya-Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.